Early Real-World Patient and Staff Experience with an Intracanalicular Dexamethasone Insert

References

• Rossi T, Romano MR, Iannetta D, et al. Cataract surgery practice patterns worldwide: a survey. BMJ Open Ophthalmol. 2021;6(1):e000464. doi:10.1136/bmjophth-2020-000464
   PubMed Web of Science ®Google Scholar
• Assil KK, Greenwood MD, Gibson A, Vantipalli S, Metzinger JL, Goldstein MH. Dropless cataract surgery: modernizing perioperative medical therapy to improve outcomes and patient satisfaction. Curr Opin Ophthalmol. 2020. doi:10.1097/ICU.0000000000000708
   Web of Science ®Google Scholar
• Hermann MM, Ustundag C, Diestelhorst M. Electronic compliance monitoring of topical treatment after ophthalmic surgery. Int Ophthalmol. 2010;30(4):385–390. doi:10.1007/s10792-010-9362-3
   PubMedGoogle Scholar
• Wu AM, Wu CM, Tseng VL, et al. Characteristics associated with receiving cataract surgery in the US Medicare and Veterans Health Administration populations. JAMA Ophthalmol. 2018;136(7):738–745. doi:10.1001/jamaophthalmol.2018.1361
   PubMed Web of Science ®Google Scholar
• Gomes BF, Paredes AF, Madeira N, Moraes HV, Santhiago MR. Assessment of eye drop instillation technique in glaucoma patients. Arq Bras Oftalmol. 2017;80(4):238–241. doi:10.5935/0004-2749.20170058
   PubMed Web of Science ®Google Scholar
• Tatham AJ, Sarodia U, Gatrad F, Awan A. Eye drop instillation technique in patients with glaucoma. Eye. 2013;27(11):1293–1298. doi:10.1038/eye.2013.187
   PubMed Web of Science ®Google Scholar
• Schwartz GF, Hollander DA, Williams JM. Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension. Curr Med Res Opin. 2013;29(11):1515–1522. doi:10.1185/03007995.2013.833898
   PubMed Web of Science ®Google Scholar
• Kashiwagi K, Matsuda Y, Ito Y, et al. Investigation of visual and physical factors associated with inadequate instillation of eyedrops among patients with glaucoma. PLoS One. 2021;16(5):e0251699. doi:10.1371/journal.pone.0251699
   PubMed Web of Science ®Google Scholar
• Stone JL, Robin AL, Novack GD, Covert DW, Cagle GD. An objective evaluation of eyedrop instillation in patients with glaucoma. Archives of Ophthalmology. 2009;127(6):732–736. doi:10.1001/archophthalmol.2009.96
   PubMedGoogle Scholar
• Shorstein NH, Myers WG. Drop-free approaches for cataract surgery. Curr Opin Ophthalmol. 2020;31(1):67–73. doi:10.1097/ICU.0000000000000625
   PubMed Web of Science ®Google Scholar
• Lindstrom RL, Galloway MS, Grzybowski A, Liegner JT. Dropless Cataract Surgery: an Overview. Curr Pharm Des. 2017;23(4):558–564. doi:10.2174/1381612822666161129150628
   PubMed Web of Science ®Google Scholar
• Bardoloi N, Sarkar S, Pilania A, Das H. Efficacy and safety of dropless cataract surgery. Indian J Ophthalmol. 2020;68(6):1081–1085. doi:10.4103/ijo.IJO_1186_19
   PubMed Web of Science ®Google Scholar
• Foster B. Same-day versus next-day dexamethasone intracanalicular insert administration for inflammation and pain control following cataract surgery: a retrospective analysis. Clin Ophthalmol. 2021;15:4091–4096. doi:10.2147/OPTH.S335764
   PubMed Web of Science ®Google Scholar
• Saenz B, Ferguson TJ, Abraham N, Mueller BH, Parkhurst GD. Evaluation of Same-Day versus Next-Day Implantation of Intracanalicular Dexamethasone for the Control of Postoperative Inflammation and Pain Following Cataract Surgery. Clin Ophthalmol. 2021;15:4615–4620. doi:10.2147/OPTH.S334297
   PubMed Web of Science ®Google Scholar
• Stephenson PDG. Real-world of postoperative in-office dexamethasone intracanalicular insert administration for control of postoperative inflammation following cataract surgery. J Clin Ophthalmol. 2020;4(3):273–278.
   Google Scholar
• Drugs@FDA: dextenza. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/208742s007lbl.pdf. Accessed May 3, 2024.
   Google Scholar
• Walters TR, Bafna S, et al. Efficacy and safety of sustained release dexamethasone for the treatment of ocular pain and inflammation after cataract surgery: results from two phase 3 studies. J Clin Exp Ophthalmol. 2016;7(4):572. doi:10.4172/2155-9570.1000572
   Google Scholar
• Tyson SL, Bafna S, Gira JP, et al. Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery. J Cataract Refract Surg. 2019;45(2):204–212. doi:10.1016/j.jcrs.2018.09.023
   PubMed Web of Science ®Google Scholar
• McLaurin EB, Evans D, Repke CS, et al. Phase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis. Am J Ophthalmol. 2021;229:288–300. doi:10.1016/j.ajo.2021.03.017
   PubMed Web of Science ®Google Scholar
• Dierker DS, Hauswirth SG. Thermal Pulsation with or without Dexamethasone Intracanalicular Insert for Meibomian Gland Dysfunction: a Prospective, Masked Trial. Clin Ophthalmol. 2022;16:1477–1485. doi:10.2147/OPTH.S359719
   PubMed Web of Science ®Google Scholar
• Ibach MJ, Shafer BM, Wallin DD, Puls-Boever KR, Thompson VM, Berdahl JP. The Effectiveness and Safety of Dextenza 0.4 mg for the Treatment of Postoperative Inflammation and Pain in Patients After Photorefractive Keratectomy: the RESTORE Trial. J Refract Surg. 2021;37(9):590–594. doi:10.3928/1081597X-20210610-05
   PubMed Web of Science ®Google Scholar
• Greenwood MD, Gorham RA, Boever KR. A Randomized Fellow-Eye Clinical Trial to Evaluate Patient Preference for Dexamethasone Intracanalicular Insert or Topical Prednisolone Acetate for Control of Postoperative Symptoms Following Bilateral Femtosecond Laser in Site Keratomileusis (LASIK). Clin Ophthalmol. 2020;14:2223–2228. doi:10.2147/OPTH.S265311
   PubMed Web of Science ®Google Scholar
• Han JV, Patel DV, Squirrell D, McGhee CN. Cystoid macular oedema following cataract surgery: a review. Clin Exp Ophthalmol. 2019;47(3):346–356. doi:10.1111/ceo.13513
   PubMed Web of Science ®Google Scholar
• Suner IJ, Peden MC. Dexamethasone Sustained-Release Intracanalicular Insert for Control of Postoperative Inflammation After Pars Plana Vitrectomy. Clin Ophthalmol. 2021;15:3859–3864. doi:10.2147/OPTH.S330255
   PubMed Web of Science ®Google Scholar
• Matossian C, Stephens JD, Rhee MK, et al. Early Real-World Physician Experience with an Intracanalicular Dexamethasone Insert. Clin Ophthalmol. 2022;16:2429–2440. doi:10.2147/OPTH.S372440
   PubMed Web of Science ®Google Scholar
• Gira JP, Sampson R, Silverstein SM, Walters TR, Metzinger JL, Talamo JH. Evaluating the patient experience after implantation of a 0.4 mg sustained release dexamethasone intracanalicular insert (Dextenza): results of a qualitative survey. Patient Prefer Adherence. 2017;11:487–494. doi:10.2147/PPA.S126283
   PubMed Web of Science ®Google Scholar
• Donnenfeld ED, Hovanesian J, Hummel C, Quintero J Dropless punctal plug dexamethasone, intracameral ketorolac and moxifloxacin compared to conventional topical therapy in cataract surgery. 2020 Virtual Annual Meeting of ASCRS: May 2020.
   Google Scholar
• Robin AL, Covert D. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy? Ophthalmology. 2005;112(5):863–868. doi:10.1016/j.ophtha.2004.12.026
   PubMed Web of Science ®Google Scholar
• Usgaonkar U, Zambaulicar V, Shetty A. Subjective and objective assessment of the eye drop instillation technique: a hospital-based cross-sectional study. Indian J Ophthalmol. 2021;69(10):2638–2642. doi:10.4103/ijo.IJO_3333_20
   PubMed Web of Science ®Google Scholar
• Gupta R, Patil B, Shah BM, Bali SJ, Mishra SK, Dada T. Evaluating eye drop instillation technique in glaucoma patients. J Glaucoma. 2012;21(3):189–192. doi:10.1097/IJG.0b013e31820bd2e1
   PubMed Web of Science ®Google Scholar